Dr. Raptis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
Pittsburgh, PA 15232Phone+1 412-864-6600Fax+1 412-864-6601
Summary
- I am board certified physician, specializing in hematologic malignancies
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1991 - 1994
University of Ioannina Faculty of MedicineClass of 1986
Certifications & Licensure
IL State Medical License 1998 - 2026
PA State Medical License 2004 - 2024
OH State Medical License 2003 - 2016
MD State Medical License 1994 - 1999- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACP) American College of Physicians, 2000
Clinical Trials
- Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Start of enrollment: 1998 Apr 01
Publications & Presentations
PubMed
- 173 citationsPembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.Maria-Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson
The Lancet. Haematology. 2019-07-18 - 162 citationsPembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trialSaad Z. Usmani, Fredrik Schjesvold, Albert Oriol, Lionel Karlin, Michele Cavo
The Lancet. Haematology. 2019-09-01 - 200 citationsCytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming UnitsJeffrey J. Molldrem, Emmanuel Clave, Yin Zheng Jiang, Dimitrios Mavroudis, Anastasios Raptis
Blood. 1997-10-01
Press Mentions
OncLive® Presents State of the Science Summit™June 3rd, 2019
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
